www.jhoonline.org

Table 2
Clinical details and RT-PCR positivity data.
	Stage	T	N	ER	PR	Grade	LVI	*TACSTD1*	*EPHB4*	*ELF3*	*EGFR*	*MGB1*

1	in situ	Tis	-	x	x	ND	-	-	-	-	-	-

2	in situ	Tis	-	+	+	ND	-	-	-	-	-	-

3	in situ	Tis	-	-	-	ND	-	-	-	-	-	-

4	in situ	Tis	-	+	+	ND	-	-	-	-	-	-

5	in situ	Tis	-	x	x	ND	-	-	-	-	-	-

6	in situ	Tis	-	x	x	ND	-	-	-	+	-	-

7	in situ	Tis	-	x	x	ND	-	+	+	+	+	-

8	In situ	Tis	x	+	+	2	-	-	-	-	-	-

9	I	T1	-	+	+	1	-	-	-	-	-	-

10	I	T1	-	+	-	1	-	-	-	-	-	-

11	I	T1	-	+	+	1	-	-	-	-	-	-

12	I	T1	-	+	+	1	-	-	-	-	-	-

13	I	T1	-	+	+	1	-	-	-	-	-	-

14	I	T1	-	+	+	1	-	-	-	-	-	-

15	I	T1	-	+	+	1		-	-	-	-	-

16	I	T1	-	+	+	1	-	+	-	-	-	-

17	I	T1	-	+	+	1	-	+	+	-	+	-

18	I	T1	-	+	+	2	-	-	-	-	-	-

19	I	T1	-	+	+	2	-	-	-	-	-	-

20	I	T1	-	-	+	2	-	-	-	-	-	-

21	I	T1	-	+	+	2	-	-	-	-	-	-

22	I	T1	-	-	-	3	-	+	+	-	-	-

23	I	T1	-	+	+	3	-	-	-	-	-	-

24	I	T1	-	+	+	3	+	+	+	+	-	-

25	I	T1	-	-	+	ND	-	-	-	-	-	-

26	IIa	T1	+	+	-	1	-	+	+	+	+	+

27	IIa	T1	+	+	+	1	-	-	-	-	-	-

28	IIa	T1	+	+	+	2	-	+	+	+	+	+

29	IIa	T1	+	+	+	2	-	+	+	+	+	+

30	IIa	T1	+	+	+	2	+	+	+	+	+	+

31	IIa	T1	+	x	x	2	+	-	-	-	-	-

32	IIa	T1	+	+	+	2	-	-	-	-	-	-

33	IIa	T1	+	-	+	3	-	+	+	+	+	-

34	IIa	T2	-	x	x	1	-	-	-	-	-	-

35	IIa	T2	-	+	+	1	-	-	-	-	-	-

36	IIa	T2	-	+	+	1	-	-	-	-	-	-

37	IIa	T2	-	+	+	1	-	-	-	-	-	-

38	IIa	T2	-	+	+	1	+	+	+	+	-	-

39	IIa	T2	-	+	+	1	+	+	+	+	+	-

40	IIa	T2	-	+	+	2	-	-	-	-	-	-

41	IIa	T2	-	+	+	2	-	-	-	-	-	-

42	IIa	T2	-	+	+	2	+	-	-	-	-	-

43	IIa	T2	-	+	+	2	-	-	-	-	-	-

44	IIa	T2	-	+	+	2	+	-	-	-	-	-

45	IIa	T2	-	-	-	3	-	-	-	-	-	-

46	IIa	T1	-	+	+	2	-	-	-	-	-	-

47	IIb	T2	+	+	+	1	-	+	+	+	+	-

48	IIb	T2	+	x	x	2	+	+	+	+	+	+

49	IIb	T2	+	+	+	3	+	+	+	+	+	+

50	IIb	T2	+	+	+	3	-	+	+	+	+	+

51	IIb	T2	+	+	-	3	+	+	+	+	+	-

52	IIb	T2	+	-	-	3	+	-	-	-	-	-

53	IIb	T3	-	-	-	3	+	+	+	+	+	-

54	IIb	T1	x	-	-	2	+	+	+	+	+	+

55	IIb	T2	x	-	-	3	+	+	+	+	+	-

56	IIIa	T3	+	x	x	2	-	+	+	+	+	-

Stage, tumour size (T), nodal status (N), estrogen receptor status (ER) and progesterone receptor status (PR), lymphovascular invasion (LVI), tumour grade, and positive or negative expression of the 5 RT-PCR markers are shown for the 56 breast cancer patients. ND denotes no data. x denotes unknown.
Raynor et al. Journal of Hematology & Oncology 2009 2:24 doi:10.1186/1756-8722-2-24

Table 2